PART II ITEM 6 Selected Financial Data Selected Financial Data ITEM 6 The selected financial data should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations and the Consolidated Financial Statements and accompanying notes included elsewhere herein. Highlights (Dollars in millions, except per share amounts) 2012 2011 2010 2009 2008 Revenues Premiums and fees and other revenues $ 26,308 $ 19,210 $ 18,528 $ 16,018 $ 16,880 Net investment income 1,144 1,146 1,105 1,014 1,063 Mail order pharmacy revenues 1,623 1,447 1,420 1,282 1,204 Realized investment gains (losses) 44 62 75 (43) (170) TOTAL REVENUES $ 29,119 $ 21,865 $ 21,128 $ 18,271 $ 18,977 Results of Operations: Global Health Care $ 1,418 $ 1,105 $ 940 $ 775 $ 732 Group Disability and Life 279 295 305 306 282 Global Supplemental Benefits 142 97 84 107 70 Run-off Reinsurance – (183) 26 185 (646) Other Operations 82 89 85 86 87 Corporate (329) (184) (211) (142) (162) Realized investment gains (losses), net of taxes and noncontrolling interest 31 41 50 (26) (110) Shareholders’ income from continuing operations 1,623 1,260 1,279 1,291 253 Income from continuing operations attributable to redeemable noncontrolling interest 1 – – – – Income from continuing operations attributable to other noncontrolling interest – 1 4 3 2 Income from continuing operations 1,624 1,261 1,283 1,294 255 Income from discontinued operations, net of taxes – – – 1 4 NET INCOME $ 1,624 $ 1,261 $ 1,283 $ 1,295 $ 259 Shareholders’ income per share from continuing operations: Basic $ 5.70 $ 4.65 $ 4.69 $ 4.71 $ 0.91 Diluted $ 5.61 $ 4.59 $ 4.65 $ 4.69 $ 0.91 Shareholders’ net income per share: Basic $ 5.70 $ 4.65 $ 4.69 $ 4.71 $ 0.93 Diluted $ 5.61 $ 4.59 $ 4.65 $ 4.69 $ 0.92 Common dividends declared per share $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.04 Total assets $ 53,734 $ 50,697 $ 45,393 $ 42,794 $ 41,206 Long-term debt $ 4,986 $ 4,990 $ 2,288 $ 2,436 $ 2,090 Shareholders’ equity $ 9,769 $ 7,994 $ 6,356 $ 5,198 $ 3,392 Per share $ 34.18 $ 28.00 $ 23.38 $ 18.95 $ 12.51 Common shares outstanding (in thousands) 285,829 285,533 271,880 274,257 271,036 Shareholders of record 7,885 8,178 8,568 8,888 9,014 Employees 35,800 31,400 30,600 29,300 30,300 Effective December 31, 2012, the Company changed its external reporting segments. See Note 23 to the Consolidated Financial Statements for additional information. Prior year segment information has been conformed to the new segment structure. See Note 2 to the Consolidated Financial Statements for further discussion of changes resulting from the retrospective adoption of amended accounting guidance for deferred policy acquisition costs in 2012. Beginning in 2010, the Company began reporting the expense associated with its frozen pension plans in Corporate. Prior periods were not restated. The effect on prior periods was not material. In 2008, the Company recorded significant charges related to the guaranteed minimum income benefits and guaranteed minimum death benefits businesses of the Run-off Reinsurance segment, as well as an after-tax litigation charge of $52 million in Corporate related to the Cigna pension plan. CIGNA CORPORATION -  2012 Form  10-K 31